Now we are looking on the crossword clue for: Apt. ad abbr.
it’s A 12 letters crossword puzzle definition.
Next time, try using the search term “Apt. ad abbr crossword” or “Apt. ad abbr crossword clue” when searching for help with your puzzle on the web. See the possible answers for Apt. ad abbr below.
Did you find what you needed?
We hope you did!. If you are still unsure with some definitions, don’t hesitate to search them here with our crossword puzzle solver.
Possible Answers: RMS.
Last seen on: –Thomas Joseph – King Feature Syndicate Crossword – Dec 23 2020
–Thomas Joseph – King Feature Syndicate Crossword – Dec 14 2020
–Thomas Joseph – King Feature Syndicate Crossword – Oct 1 2020
Wall Street Journal Crossword – Oct 3 2017 – Troublesome
Random information on the term “RMS”:
Rhabdomyosarcoma, or RMS, is an aggressive and highly malignant form of cancer that develops from skeletal (striated) muscle cells that have failed to fully differentiate. It is generally considered to be a disease of childhood, as the vast majority of cases occur in those below the age of 18. It is commonly described as one of the “small, round, blue cell tumours of childhood” due to its appearance on an H&E stain. Despite being a relatively rare cancer, it accounts for approximately 40% of all recorded soft tissue sarcomas. RMS can occur in any site on the body, but is primarily found in the head, neck, orbit, genitourinary tract, genitals, and extremities. There are no clear risk factors for RMS, but the disease has been associated with some congenital abnormalities. Signs and symptoms vary according to tumor site, and prognosis is closely tied to the location of the primary tumor. Common site of metastasis include the lungs, bone marrow, and bones. There are many classification systems for RMS and a variety of defined histological types. Embryonal rhabdomyosarcoma is the most common type and comprises about 60% of cases. Patient outcomes vary considerably, with 5 years survival rates between 35% and 95% depending on the type of RMS involved, so clear diagnosis is critical for effective treatment and management. Unfortunately, accurate and quick diagnosis is often difficult due to the heterogeneity of RMS tumors and a lack of strong genetic markers of the disease. Treatment usually involves a combination of surgery, chemotherapy, and radiation. Sixty percent to 70% of newly diagnosed patients with nonmetastatic disease can be cured using this combined approach to therapy. Despite aggressive multimodality treatment, less than 20% of patients with metastatic RMS are able to be cured of their disease.